FDA Issues form 483 to Contract Pharmaceuticals Limited Canada
04 Apr 2024 //
FDA
Enforcement Report - Week of March 13, 2024
13 Mar 2024 //
FDA
Contract Pharmacal`s Generic Famotidine Receives Approval in the U.S.
20 Dec 2023 //
FDA
Contract Pharmacal Welcomes Larry Lapila as VP of Business Development
23 Jun 2023 //
ACCESSWIRE
Contract Pharmacal Corp. Wins CVS’s 2022 Leading With Heart Award
22 Jun 2023 //
PRESS RELEASE
Contract Pharmacal Corp. Welcomes Glenn Langberg as Chief Strategy Officer
09 Jun 2023 //
PRESS RELEASE
Enforcement Report - Week of February 19, 2020
20 Feb 2020 //
FDA